Adjuvant internal radiation therapy in a model of colorectal cancer-derived hepatic metastases.
Selective internal radiation therapy (SIR therapy) is a technique whereby metastatic liver cancer is irradiated by embolising microspheres containing the radionuclide yttrium-90 into the hepatic arterial circulation. To date this technique has not been used as an adjuvant therapy, but rather to treat established metastases in the liver. This study evaluated the use of two intrahepatic radiation doses delivered on radioactive microspheres for the treatment of small, growing micrometastases. Three groups of five rats were each inoculated with tumour spheroids into the portal vein. The resultant liver micrometastases were treated with either 10 or 20 MBq of yttrium-90 microspheres or a sham dose of non-radioactive microspheres injected into the portal vein 2 days following tumour inoculation. The livers of each animal were examined for the presence of metastases after a further 21 days and liver function tests were performed. At the time of sacrifice there was no obvious normal liver damage in any of the rats treated with microspheres. The livers of the sham-treated animals contained extensive signs of tumour deposition. A mean of 34 tumours were taken from the livers of each of the sham-treated animals, whereas only a single tumour was found in one animal treated with 10 MBq of yttrium and eight small tumours from two animals treated with 20 MBq. Liver function tests demonstrated a significant short-term increase in alkaline phosphatase levels in the radiation-treated animals compared with shams, but there were no other indications of any effects on liver function. These results indicate a potential role for SIR therapy in an adjuvant setting with colorectal cancer.
School of Science and Technology, Charles Sturt University, Wagga Wagga, Australia.
M A
MA
Burton
B N
BN
Gray
D000818:Animals; D015179:Colorectal Neoplasms / Q000473:pathology*; D004307:Dose-Response Relationship, Radiation; D005260:Female; D007275:Injections, Intravenous; D008099:Liver / Q000528:radiation effects; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000532:radiotherapy / Q000556:secondary*; D008297:Male; D008863:Microspheres; D009368:Neoplasm Transplantation; D011169:Portal Vein; D018714:Radiotherapy, Adjuvant; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D015021:Yttrium Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*
D015021:Yttrium Radioisotopes